A cost-benefit analysis of the COVID-19 disease

被引:60
|
作者
Rowthorn, Robert [1 ]
Maciejowski, Jan [2 ]
机构
[1] Univ Cambridge, Econ, Cambridge, England
[2] Univ Cambridge, Control Engn, Cambridge, England
关键词
COVID-19; benefit-cost; lockdown; PUBLIC AVOIDANCE;
D O I
10.1093/oxrep/graa030
中图分类号
F [经济];
学科分类号
02 ;
摘要
The British government has been debating how to escape from the lockdown without provoking a resurgence of the COVID-19 disease. There is a growing recognition of the damage the lockdown has caused to economic and social life. This paper presents a simple cost-benefit analysis inspired by optimal control theory and incorporating the SIR model of disease propagation. It also reports simulations informed by the theoretical discussion. The optimal path for government intervention is computed under a variety of conditions. These include a cap on the permitted level of infection to avoid overload of the health system, and the introduction of a test and trace system. We quantify the benefits of early intervention to control the disease. We also examine how the government's valuation of life influences the optimal path. A 10-week lockdown is only optimal if the value of life for COVID-19 victims exceeds 10m pound. The study is based on a standard but simple epidemiological model, and should therefore be regarded as presenting a methodological framework rather than giving policy prescriptions.
引用
收藏
页码:S38 / S55
页数:18
相关论文
共 50 条
  • [1] COVID-19: Cost-Benefit Analysis and Politics
    Priel, Dan
    OSGOODE HALL LAW JOURNAL, 2020, 57 (03): : 537 - 565
  • [2] A cost-benefit analysis of COVID-19 lockdowns in Australia
    Lally, Martin
    MONASH BIOETHICS REVIEW, 2022, 40 (01) : 62 - 93
  • [3] A Cost-Benefit Analysis of COVID-19 Vaccination in Catalonia
    Lopez, Francesc
    Catala, Marti
    Prats, Clara
    Estrada, Oriol
    Oliva, Irene
    Prat, Nuria
    Isnard, Mar
    Valles, Roser
    Vilar, Marc
    Clotet, Bonaventura
    Argimon, Josep Maria
    Aran, Anna
    Ara, Jordi
    VACCINES, 2022, 10 (01)
  • [4] A social cost-benefit framework for COVID-19 policy decisions
    Heatley, Dave
    NEW ZEALAND ECONOMIC PAPERS, 2022, 56 (01) : 41 - 48
  • [5] Cost-benefit of limited isolation and testing in COVID-19 mitigation
    Eilersen, Andreas
    Sneppen, Kim
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [6] Cost-benefit analysis of the COVID-19 vaccination model incorporating different infectivity reductions
    Appiah, Raymond Fosu
    Jin, Zhen
    Yang, Junyuan
    Asamoah, Joshua Kiddy K.
    FRONTIERS IN PHYSICS, 2024, 12
  • [7] The effect of incorporating infectious disease dynamics into a social cost-benefit framework for COVID-19 policy decisions
    Hendy, Shaun C.
    NEW ZEALAND ECONOMIC PAPERS, 2024,
  • [8] A cost–benefit analysis of COVID-19 lockdowns in Australia
    Martin Lally
    Monash Bioethics Review, 2022, 40 : 62 - 93
  • [9] A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona
    Lopez Segui, Francesc
    Estrada Cuxart, Oriol
    Mitja i Villar, Oriol
    Hernandez Guillamet, Guillem
    Prat Gil, Nuria
    Maria Bonet, Josep
    Isnard Blanchar, Mar
    Moreno Millan, Nemesio
    Blanco, Ignacio
    Vilar Capella, Marc
    Catala Sabate, Marti
    Aran Sole, Anna
    Argimon Pallas, Josep Maria
    Clotet, Bonaventura
    Ara del Rey, Jordi
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (13)
  • [10] The benefits of coronavirus suppression: A cost-benefit analysis of the response to the first wave of COVID-19 in the United States
    Broughel, James
    Kotrous, Michael
    PLOS ONE, 2021, 16 (06):